EA202090569A1 - NON-INVASIVE DIAGNOSTICS OF NON-ALCOHOLIC FATAL DYSTROPHIES OF THE LIVER, NON-ALCOHOLIC STEATHEPATITIS AND / OR LIVER FIBROSIS - Google Patents

NON-INVASIVE DIAGNOSTICS OF NON-ALCOHOLIC FATAL DYSTROPHIES OF THE LIVER, NON-ALCOHOLIC STEATHEPATITIS AND / OR LIVER FIBROSIS

Info

Publication number
EA202090569A1
EA202090569A1 EA202090569A EA202090569A EA202090569A1 EA 202090569 A1 EA202090569 A1 EA 202090569A1 EA 202090569 A EA202090569 A EA 202090569A EA 202090569 A EA202090569 A EA 202090569A EA 202090569 A1 EA202090569 A1 EA 202090569A1
Authority
EA
Eurasian Patent Office
Prior art keywords
alcoholic
liver
steathepatitis
dystrophies
fatal
Prior art date
Application number
EA202090569A
Other languages
Russian (ru)
Inventor
Реми Анф
Женевьев Кордоннье
Джон Брозек
Original Assignee
Женфит
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Женфит filed Critical Женфит
Priority claimed from PCT/EP2018/073050 external-priority patent/WO2019038456A1/en
Publication of EA202090569A1 publication Critical patent/EA202090569A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Настоящее изобретение относится к новому неинвазивному способу диагностики неалкогольной жировой дистрофии печени, в частности неалкогольного стеатогепатита и/или фиброза печени.The present invention relates to a new non-invasive method for the diagnosis of non-alcoholic fatty liver disease, in particular non-alcoholic steatohepatitis and / or liver fibrosis.

EA202090569A 2017-11-03 2018-08-27 NON-INVASIVE DIAGNOSTICS OF NON-ALCOHOLIC FATAL DYSTROPHIES OF THE LIVER, NON-ALCOHOLIC STEATHEPATITIS AND / OR LIVER FIBROSIS EA202090569A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17200028 2017-11-03
PCT/EP2018/073050 WO2019038456A1 (en) 2017-08-25 2018-08-27 Non-invasive diagnostic of non-alcoholic fatty liver diseases, non-alcoholic steatohepatitis and/or liver fibrosis

Publications (1)

Publication Number Publication Date
EA202090569A1 true EA202090569A1 (en) 2020-06-03

Family

ID=60421559

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202090569A EA202090569A1 (en) 2017-11-03 2018-08-27 NON-INVASIVE DIAGNOSTICS OF NON-ALCOHOLIC FATAL DYSTROPHIES OF THE LIVER, NON-ALCOHOLIC STEATHEPATITIS AND / OR LIVER FIBROSIS

Country Status (1)

Country Link
EA (1) EA202090569A1 (en)

Similar Documents

Publication Publication Date Title
EA202090715A1 (en) NON-INVASIVE DIAGNOSTICS OF NON-ALCOHOLIC FAT LIVER DYSTROPHIES, NON-ALCOHOLIC STEATHEPATITIS AND / OR LIVER FIBROSIS
PH12020500164A1 (en) Non-invasive diagnostic of non-alcoholic fatty liver diseases, non-alcoholic steatohepatitis and/or liver fibrosis
EA201892201A1 (en) NON-INVASIVE DIAGNOSTICS OF NON-ALCOHOL STEATOPEPATITIS
SG10201903823QA (en) Methods and compositions relating to microbial treatment and diagnosis of disorders
EA201500995A1 (en) BISPECIFIC ANTIBODIES, SPECIFIC FOR THE FAP AND DR5, ANTIBODIES, THE SPECIFIC FOR THE DR5, AND METHODS OF THEIR APPLICATION
EA201690199A1 (en) Drug for the treatment of non-alcoholic fatty liver disease
EA201790407A1 (en) PROBES FOR VISUALIZATION PROTEIN HANTINGTIN
WO2016098079A3 (en) Compositions and methods for antibodies targeting bmp6
EA201691541A1 (en) NEW ANTI-BAFF ANTIBODIES
EA201890747A1 (en) METHODS OF TREATING INFLAMMATORY DISEASES
EA201790432A1 (en) PROBES FOR VISUALIZATION PROTEIN HANTINGTIN
WO2017066712A3 (en) Modulators of telomere disease
EA201790400A1 (en) PROBES FOR VISUALIZATION PROTEIN HANTINGTIN
WO2015138532A3 (en) Methods for the treatment of kidney fibrosis
CO2017001087A2 (en) Anti angiopoietin-like protein 4 antibodies
WO2017066796A3 (en) Modulators of telomere disease
SG11202102684VA (en) Treatment for non-alcoholic fatty liver disease
EA201692518A2 (en) METHODS TO IMPROVE MYOCARDIAL PERFORMANCE IN PATIENTS AFTER FONTENE OPERATION USING UDENAFIL COMPOSITIONS
WO2017029558A3 (en) Methods for improving health of farmed fish
EA201790699A1 (en) STABILIZED DERIVATIVES OF ADRENOMEDULLINE AND THEIR APPLICATION
WO2016183223A3 (en) Targeted protein contrast agents, methods of making, and uses thereof
IT201700081383A1 (en) VARIATION OF OLEAGINOUS YEAST AND ITS USE FOR THE PRODUCTION OF LIPIDS.
EA202090569A1 (en) NON-INVASIVE DIAGNOSTICS OF NON-ALCOHOLIC FATAL DYSTROPHIES OF THE LIVER, NON-ALCOHOLIC STEATHEPATITIS AND / OR LIVER FIBROSIS
MX2017006747A (en) Fatty acid amides for the prevention and/or treatment of steatohepatitis.
WO2016138538A3 (en) Therapeutic use of integrin-binding antibodies